Suchergebnisse - "Papazoglou, Despoina"

PubPharm (10)

1

Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy : immune monitoring from the E1912 trial

enthalten in: Blood | 2024

von Papazoglou, D. | Wang, X. | Shanafelt, T. | +9

CommentIn: Blood. 2024 Jan 4;143(1):5-7. - PMID 38175677

2

The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy

enthalten in: Haematologica | 2023

von Arruga, F. | Rubin, M. | Papazoglou, D. | +13

3

Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma

enthalten in: The Journal of clinical investigation | 2023

von Apollonio, B. | Spada, F. | Petrov, N. | +28

CommentIn: J Clin Invest. 2023 Jul 3;133(13):. - PMID 37395274

4

Loss of TET2 in human hematopoietic stem cells alters the development and function of neutrophils

enthalten in: Cell stem cell | 2023

von Huerga Encabo, H. | Aramburu, I. | Garcia-Albornoz, M. | +19

5

Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy

enthalten in: Blood | 2021

von Ioannou, N. | Hagner, P. | Stokes, M. | +19

CommentIn: Blood. 2021 Jan 14;137(2):150-151. - PMID 33443561

6

Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy

enthalten in: Frontiers in oncology | 2021

von Apollonio, B. | Ioannou, N. | Papazoglou, D. | +1

7

T-Cell Dynamics in Chronic Lymphocytic Leukemia under Different Treatment Modalities

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Vardi, A. | Vlachonikola, E. | Papazoglou, D. | +17

8

Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia

enthalten in: International journal of cancer | 2019

von Papakonstantinou, N. | Ntoufa, S. | Tsagiopoulou, M. | +28

9

Combination lenalidomide-rituximab immunotherapy activates anti-tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma

enthalten in: British journal of haematology | 2019

von Chiu, H. | Trisal, P. | Bjorklund, C. | +11

10

Combination lenalidomide‐rituximab immunotherapy activates anti‐tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma

enthalten in: British Journal of Haematology | 2019

von Chiu, H. | Trisal, P. | Bjorklund, C. | +11

1
[1]